0001181431-12-035283.txt : 20120607 0001181431-12-035283.hdr.sgml : 20120607 20120607181457 ACCESSION NUMBER: 0001181431-12-035283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120606 FILED AS OF DATE: 20120607 DATE AS OF CHANGE: 20120607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEDOUX MARK A CENTRAL INDEX KEY: 0001115556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15701 FILM NUMBER: 12895782 MAIL ADDRESS: STREET 1: 1185 LINDA VISTA DR CITY: SAN MARCOS STATE: CA ZIP: 92069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC CENTRAL INDEX KEY: 0000787253 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 841007839 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1185 LINDA VISTA DR CITY: SAN MARCOS STATE: CA ZIP: 92069 BUSINESS PHONE: 6197447340 MAIL ADDRESS: STREET 1: 1185 LINDA VISTA DRIVE CITY: SAN MARCOS STATE: CA ZIP: 92069 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC DATE OF NAME CHANGE: 19860929 4 1 rrd348013.xml LEDOUX FORM 4 X0305 4 2012-06-06 0 0000787253 NATURAL ALTERNATIVES INTERNATIONAL INC NAII 0001115556 LEDOUX MARK A 1185 LINDA VISTA DR SAN MARCOS CA 92078 1 1 1 0 CEO/Chairman Common Stock 2012-06-06 4 S 0 10000 6.74 D 185037 D Common Stock 2012-06-07 4 G 0 2000 D 183037 D Common Stock 2012-06-06 4 S 0 20000 6.74 D 557851 I By LeDoux Family Limited Partnership Common Stock 41416 I By IRA Common Stock 7200 I By Self as Custodian for Marcelle Jeannette LeDoux Common Stock 800 I By Self as Custodian for Jean-Marc Emile LeDoux Common Stock 28000 I By 401(K) Common Stock 36677 I By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992 This transaction represents a repurchase of common stock by the Company in a private transaction. The repurchase was approved by the Audit Committee and the independent members of the Company's Board of Directors on May 25, 2012. The approval of the Company's Audit Committee and Board of Directors was conditioned on a purchase price equal to 90% of the closing price of the Company's common stock as reported by Nasdaq on June 1, 2012, which date represented the third day after the filing by the Company of a Current Report on Form 8-K reporting the approval of the repurchase. The closing price on June 1, 2012 as reported by Nasdaq was $7.49. This transaction represents a donation of the shares to a private institution. /s/ Ken Wolf on behalf of Mr. LeDoux pursuant to a Power of Attorney 2012-06-07